ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710530; 2) Community: the network communities that were significantly associated with the response to NSC 710530; 3) Molecule: the relationships between components within communities and NSC 710530; 4) MDR: the compounds that were significantly associated with the NSC 710530.

NSC Compound Enrichment Correlation
NSC 676794 Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[3-O-(D-.apio.-.beta.-D-ribofuranosy)- 4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-D-xylopy 0.0291420747327558 0.0076769589
NSC 681972 Null 0.0291420747327558 0.47435549
NSC 682996 Null 0.0291420747327558 0.38349335
NSC 685285 Null 0.0291420747327558 -0.010378978
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.0291420747327558 0.25252541
NSC 701102 2H-1-Benzopyran-2-one, 6-chloro-3-[6-chloroimidazo[1,2-a]pyridin-2-yl]- 0.0291420747327558 0.51942344
NSC 709974 Null 0.0291420747327558 0.29139102
NSC 718781 Erlotinib hydrochloride 0.029142074732756 -0.22807632
NSC 726217 Combretastatin A4-analogue 0.029142074732756 0.49724369
NSC 744688 Null 0.029142074732756 0.49734737
Total:59  Current:40    [First] [Prev] [Next] [Last]